Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lamb

Showing results (21-30 of 244) with videos related to

Pageof 25
Sort By:
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|July 11, 2020
Rosuvastatin/Ezetimibe: A Review in HypercholesterolemiaYvette N Lamb
Drugs|September 2, 2020
Remdesivir: First ApprovalYvette N Lamb
Drugs|September 21, 2017
Glecaprevir/Pibrentasvir: First Global ApprovalYvette N Lamb
Drugs|April 22, 2018
Burosumab: First Global ApprovalYvette N Lamb
Drugs|November 25, 2024
Fulzerasib: First ApprovalYvette N Lamb
Drugs|October 15, 2025
Sepiapterin: First ApprovalYvette N Lamb
Drugs|November 26, 2019
Correction to: Cell-Based Quadrivalent Inactivated Influenza Virus Vaccine (Flucelvax<sup>®</sup> Tetra/Flucelvax Quadrivalent<sup>®</sup>): A Review in the Prevention of InfluenzaYvette N Lamb
Clinical Drug Investigation|November 30, 2019
Correction to: Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis: A Profile of Its UseYvette N Lamb
Drugs|March 25, 2021
Nintedanib: A Review in Fibrotic Interstitial Lung DiseasesYvette N Lamb
Drugs|August 3, 2019
Cell-Based Quadrivalent Inactivated Influenza Virus Vaccine (Flucelvax<sup>®</sup> Tetra/Flucelvax Quadrivalent<sup>®</sup>): A Review in the Prevention of InfluenzaYvette N Lamb
Pageof 25

Showing results (21-30 of 244) with videos related to

Sort By:
Pageof 25
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|July 11, 2020
Rosuvastatin/Ezetimibe: A Review in HypercholesterolemiaYvette N Lamb
Drugs|September 2, 2020
Remdesivir: First ApprovalYvette N Lamb
Drugs|September 21, 2017
Glecaprevir/Pibrentasvir: First Global ApprovalYvette N Lamb
Drugs|April 22, 2018
Burosumab: First Global ApprovalYvette N Lamb
Drugs|November 25, 2024
Fulzerasib: First ApprovalYvette N Lamb
Drugs|October 15, 2025
Sepiapterin: First ApprovalYvette N Lamb
Drugs|November 26, 2019
Correction to: Cell-Based Quadrivalent Inactivated Influenza Virus Vaccine (Flucelvax<sup>®</sup> Tetra/Flucelvax Quadrivalent<sup>®</sup>): A Review in the Prevention of InfluenzaYvette N Lamb
Clinical Drug Investigation|November 30, 2019
Correction to: Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis: A Profile of Its UseYvette N Lamb
Drugs|March 25, 2021
Nintedanib: A Review in Fibrotic Interstitial Lung DiseasesYvette N Lamb
Drugs|August 3, 2019
Cell-Based Quadrivalent Inactivated Influenza Virus Vaccine (Flucelvax<sup>®</sup> Tetra/Flucelvax Quadrivalent<sup>®</sup>): A Review in the Prevention of InfluenzaYvette N Lamb
Pageof 25